← Browse by Condition
Medical Condition

anaplastic lymphoma kinase genomic tumor aberrations

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06362369 Phase 1, Phase 2
Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Enrollment
126 pts
Location
United States
Sponsor
7 Hills Pharma, LLC
View Trial →